The global veterinary oncology market size was valued at US$ 401.8 million in 2018, and is expected to witness a CAGR of 10.9% over the forecast period (2019–2026).
Market Drivers
Increasing cases of canine cancer is expected to propel growth in the global veterinary oncology market over the forecast period. For instance, cancer affects 1 in every 3 dogs during their lifetime, in Australia, according to the Australia Canine Center’s 2014 data.
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/2995
Moreover, high spending on veterinary care is also expected to propel growth in the global veterinary oncology market over the forecast period. For instance, the overall spending in the U.S. veterinary care was US$ 66.75 billion in 2016 and reached US$ 69.51 billion in 2017, according to the American Pet Products Association’s March 2018 report.
Market Opportunities
Funding for R&D is expected to offer lucrative growth opportunities for players in the global veterinary oncology market. For instance, in 2017, the Blue Buffalo Foundation granted US$ 1 million to Animal Cancer Foundation for R&D in cancers in people and pets.
Moreover, R&D in veterinary cancer is also expected to offer lucrative growth opportunities for players in the global veterinary oncology market. For instance, in 2015, a team of scientists at the University of Veterinary Medicine, Vienna, initiated R&D in cancer progression in canine cell lines.
Market Restraints
High cost of treatment is expected to hinder growth of the global veterinary oncology market. For instance, the cost of diagnosis of cancer in animals is US$ 1,000 – US$ 2,000. Moreover, use of chemotherapy in the treatment of cancer in animals is US$ 3,000– US$ 5,000.
Key Players
Major players operating in the global veterinary oncology market include, AdvaVet, Inc., AB Science, Boehringer Ingelheim International GmbH, Elanco, Karyopharm Therapeutics, Inc., Morphogenesis, Inc., Regeneus Ltd., Rhizen Pharmaceutical SA, VetDC Inc., Zenoaq, and Zoetis Inc.
Key Developments
Major players operating in the global veterinary oncology market are focused on adopting merger and acquisition strategies to expand their product portfolio. For instance, in April 2019, Elanco Animal Health acquired Aratana Therapeutics, a pet therapeutics company.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/2995
Segmentation
On the basis of animal type, the global veterinary oncology market is segmented into:
- Companion Animal
- Equine
- Canine
- Feline
- Livestock Animal
On the basis of therapy type, the global veterinary oncology market is segmented into:
- Chemotherapy
- Combination Therapy
- Immunotherapy
- Targeted Therapy
On the basis of mode of administration, the global veterinary oncology market is segmented into:
- Oral
- Intravenous
On the basis of application, the global veterinary oncology market is segmented into:
- Canine Lymphoma
- Osteosarcoma (OSA)
- Mast Cell Cancer
- Melanoma
- Multiple Myeloma
On the basis of distribution channel, the global veterinary oncology market is segmented into:
- Hospital Pharmacies
- Government Agencies
- Retail Pharmacies
On the basis of region, the global veterinary oncology market is segmented into:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
𝗕𝘂𝘆 𝗡𝗼𝘄 𝗧𝗼 𝗚𝗲𝘁 𝗙𝗹𝗮𝘁 30% 𝗢𝗳𝗳
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/2995
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Veterinary Oncology Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Veterinary Oncology Industry Impact
Chapter 2 Global Veterinary Oncology Competition by Types, Applications, and Top Regions and Countries
2.1 Global Veterinary Oncology (Volume and Value) by Type
2.3 Global Veterinary Oncology (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Veterinary Oncology Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Veterinary Oncology Market Analysis
Chapter 6 East Asia Veterinary Oncology Market Analysis
Chapter 7 Europe Veterinary Oncology Market Analysis
Chapter 8 South Asia Veterinary Oncology Market Analysis
Chapter 9 Southeast Asia Veterinary Oncology Market Analysis
Chapter 10 Middle East Veterinary Oncology Market Analysis
Chapter 11 Africa Veterinary Oncology Market Analysis
Chapter 12 Oceania Veterinary Oncology Market Analysis
Chapter 13 South America Veterinary Oncology Market Analysis
Chapter 14 Company Profiles and Key Figures in Veterinary Oncology Business
Chapter 15 Global Veterinary Oncology Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
Continued….
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837